Cargando…

T cell immunity to SARS-CoV-2 following natural infection and vaccination

SARS-CoV-2 first emerged in the human population in late 2019 in Wuhan, China, and in a matter of months, spread across the globe resulting in the Coronavirus Disease 19 (COVID-19) pandemic and substantial economic fallout. SARS-CoV-2 is transmitted between humans via respiratory particles, with inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiPiazza, Anthony T., Graham, Barney S., Ruckwardt, Tracy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584424/ https://www.ncbi.nlm.nih.gov/pubmed/33190827 http://dx.doi.org/10.1016/j.bbrc.2020.10.060

Ejemplares similares

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
por: DiPiazza, Anthony T., et al.
Publicado: (2021)

SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
por: Pitiriga, Vassiliki C., et al.
Publicado: (2023)

SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination
por: Vespa, Simone, et al.
Publicado: (2022)

Waning immunity to SARS-CoV-2 following vaccination or infection
por: Hernandez-Suarez, Carlos, et al.
Publicado: (2022)

Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
por: Yang, Yongping, et al.
Publicado: (2023)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
por: Cortellini, Alessio, et al.
Publicado: (2022)

Distinct immune responses in the early phase to natural SARS‐CoV‐2 infection or vaccination
por: Peng, Pai, et al.
Publicado: (2022)

Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection
por: Franchi, Matteo, et al.
Publicado: (2023)

SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
por: Townsend, Jeffrey P., et al.
Publicado: (2022)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

SARS -CoV-2 T-cell immunity to variants of concern following vaccination
por: Gallagher, Kathleen M.E., et al.
Publicado: (2021)

Immunity to SARS‐CoV‐2 induced by infection or vaccination
por: Castro Dopico, Xaquin, et al.
Publicado: (2021)

Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103+ dendritic cell populations following respiratory infection
por: Ruckwardt, Tracy J, et al.
Publicado: (2017)

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
por: Zhou, Tongqing, et al.
Publicado: (2020)

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
por: Zhou, Tongqing, et al.
Publicado: (2020)

Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection
por: De Giorgi, Valeria, et al.
Publicado: (2021)

Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022)

A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
por: Torresi, Joseph, et al.
Publicado: (2022)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
por: Souza, William M, et al.
Publicado: (2021)

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
por: Garg, Pramod Kumar, et al.
Publicado: (2022)

Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
por: Wang, Lingshu, et al.
Publicado: (2021)

Immune responses to SARS-CoV-2 infection and vaccination in children
por: Brodin, Petter
Publicado: (2023)

Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination
por: Feschuk, Aileen M., et al.
Publicado: (2023)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
por: Yue, Can, et al.
Publicado: (2023)

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
por: Pušnik, Jernej, et al.
Publicado: (2023)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Immune Dysregulation in Acute SARS-CoV-2 Infection
por: Grimm, Lauren, et al.
Publicado: (2023)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
por: Wang, Lingshu, et al.
Publicado: (2021)

Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
por: Loomis, Rebecca J., et al.
Publicado: (2021)

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
por: Sui, Yongjun, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells in infection and vaccination
por: Bertoletti, Antonio, et al.
Publicado: (2021)

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination
por: Yin, Zixi, et al.
Publicado: (2023)

Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
por: de Oliveira-Filho, Edmilson F., et al.
Publicado: (2022)

Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients
por: Prasad, Narayan, et al.
Publicado: (2022)

Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-CoV-2: a comparative paired analysis
por: AbdelWareth, Laila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1prh6u0vqk3b36dmdt6cehapfs